explore -WSS

explore

author：Wikipedia 2025-09-28 20:44:16 - browse：2649

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： ReNAgade cuts staff seven months after raising $300 million

Wikipedia

WSS

Plane’s emergency slide plummets from sky, hits Chicago home

What to do when lifesaving products contribute to climate change

Stanford president to resign after investigation of research

Seattle police shoot person suspected in downtown stabbing

Cigna, Humana reportedly in talks to merge

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

explore

explore

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

As biotech industry slumps, bioscience job market is upside down

Dobbs anniversary: the lost opportunity of abortion as health care

Plane’s emergency slide plummets from sky, hits Chicago home

Dobbs anniversary: the lost opportunity of abortion as health care

Lindsay Lohan welcomes 1st child with husband Bader Shammas

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

States increasingly look to regulate hospital facility fees

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Plane’s emergency slide plummets from sky, hits Chicago home

hotspot

Resistance to cancer drugs: A new genetic explanation

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

ReNAgade cuts staff seven months after raising $300 million

UnitedHealth’s Optum accused of antitrust violations in California

Rep. Raul Ruiz on the physician shortage and more

BIO selects John Crowley as new CEO

focus

Wikipedia

hotspot

focus